GlassScriptPhysician profile
Sabarina Ramanathan
NPI 1962893636
$732.46
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2022: $160 · 2023: $118 · 2024: $97.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $230.30 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $129.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $111.45 | 2022-2024 | |
| Pfizer INC. | $99.18 | 2019 | |
| Tempus Ai, INC | $43.51 | 2024 | |
| Janssen Biotech, INC. | $31.97 | 2022-2023 | Erleada |
| Celgene Corporation | $26.12 | 2023 | Pomalyst |
| Abbvie INC. | $17.67 | 2023 | |
| Morphosys, US INC. | $16.94 | 2022 | |
| Gilead Sciences, INC. | $16.14 | 2023 | Trodelvy |
| Sirtex Medical INC | $9.79 | 2023 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabarina Ramanathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.